at Zacks.com (Thu, 10:51AM)
Celgene's (CELG +1.6%) board has authorized the repurchase of up to an extra $3B in shares, having exhausted a previous $2.5B buyback program. So far this year, the company has repurchased $1.8B in stock. (See apremilast results) (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Thu, 8:59AM)
at Zacks.com (Tue, 4:45PM)
at Zacks.com (Jan 22, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs